231 related articles for article (PubMed ID: 9724860)
21. Single dose 'ROM' therapy--is it really effective?
Mandal AK
Natl Med J India; 1998; 11(5):247. PubMed ID: 10997176
[No Abstract] [Full Text] [Related]
22. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
[TBL] [Abstract][Full Text] [Related]
23. Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis.
Setia MS; Shinde SS; Jerajani HR; Boivin JF
Trop Med Int Health; 2011 Dec; 16(12):1541-51. PubMed ID: 21914093
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
Manickam P; Nagaraju B; Selvaraj V; Balasubramanyam S; Mahalingam VN; Mehendale SM; Pannikar VK; Gupte MD;
Indian J Lepr; 2012; 84(3):195-207. PubMed ID: 23484334
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group.
Indian J Lepr; 1997; 69(2):121-9. PubMed ID: 9290963
[TBL] [Abstract][Full Text] [Related]
26. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
Sampoonachot P; Bundit C; Kuhacharoen N; Peerapakorn S; Kampirapap K; Poomlek A; Bampenyu S; Tiasiri S; Rungruang S; Surasondhi S; Supanwanit S; Wiriyawipart S
J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
[TBL] [Abstract][Full Text] [Related]
27. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Lockwood DN; Cunha Mda G
Lepr Rev; 2012 Sep; 83(3):241-4. PubMed ID: 23356024
[No Abstract] [Full Text] [Related]
28. Chemotherapy of leprosy.
Biswas SK;
J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354
[TBL] [Abstract][Full Text] [Related]
29. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
Sousa AL; Stefani MM; Pereira GA; Costa MB; Rebello PF; Gomes MK; Narahashi K; Gillis TP; Krahenbuhl JL; Martelli CM
Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation years in leprosy patients treated with single dose alternative scheme ROM (rifampin, ofloxacin, minocycline), after seven to nine].
Diniz LM; Catabriga MD; Souza Filho JB
Rev Soc Bras Med Trop; 2010; 43(6):695-9. PubMed ID: 21181026
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
Kumar A; Girdhar A; Girdhar BK
Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
[TBL] [Abstract][Full Text] [Related]
32. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
Lockwood DN
Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
[No Abstract] [Full Text] [Related]
33. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
Pattyn S; Grillone S
Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
[TBL] [Abstract][Full Text] [Related]
34. Population screening and chemoprophylaxis for household contacts of leprosy patients in the Republic of the Marshall Islands.
Tin K
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S26-9. PubMed ID: 10700934
[No Abstract] [Full Text] [Related]
35. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
Suneetha S; Reddy R
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
[No Abstract] [Full Text] [Related]
36. Elimination of leprosy in the federated states of micronesia by intensive case finding, treatment with WHO/MDT and administration of chemoprophylaxis.
Diletto C
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S10-3. PubMed ID: 10700929
[No Abstract] [Full Text] [Related]
37. Multibacillary leprosy: follow up observations on 19 patients treated with 12 monthly doses of rifampicin, ofloxacin and minocycline therapy in Agra.
Kumar A; Girdhar BK
Indian J Dermatol Venereol Leprol; 2014; 80(2):156-9. PubMed ID: 24685858
[No Abstract] [Full Text] [Related]
38. Population screening and mass chemoprophylaxis in Kiribati.
Daulako EC
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S23-5. PubMed ID: 10700933
[No Abstract] [Full Text] [Related]
39. A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
Pattyn S; Grillone S
Lepr Rev; 2000 Mar; 71(1):43-6. PubMed ID: 10820986
[No Abstract] [Full Text] [Related]
40. Lesional characteristics and histopathology in paucibacillary leprosy patients with 2 or 3 skin lesions: comparison between ROM and PB-MDT regimens.
Emmanuel M; Gupte MD
Indian J Lepr; 2005; 77(1):19-25. PubMed ID: 16173416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
